Fig. 3
From: Interconnectivity between molecular subtypes and tumor stage in colorectal cancer
Lymph node assessment and disease free survival. a shows the distribution of CMS in stage II colon cancer (y-axis distribution in percentages) stratified for high-risk. b and c display the disease free survival (x-axis in months) of a set of patients with stage II colon cancer of the MATCH Cohort and GSE33113 (b), and the subset of patients with high-risk stage II colon cancer (T4 or < 10 assessed lymph nodes) (c). d shows that the chance of finding a positive lymph node (y-axis) increases with an increasing number of assessed lymph nodes (x-axis), which plateaus after 10 lymph nodes